RLAY ($RLAY) Insider Trading & Smart Money Activity

RLAY · Biotechnology · Latest filing Oct 7, 2026

$RLAY has 5 insider trades on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($1.20M), net -$1.20M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
2
Net insider $ (12 mo)
-$1.20M
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

RLAY insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 2 · $1.20M 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All RLAY insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Patel SanjivPresident and CEO Sell (Open-market sale) 10b5-1 48.20K sh $872.40K -5.0% —
Insider Catinazzo ThomasChief Financial Officer Sell (Open-market sale) 10b5-1 17.72K sh $329.32K -7.4% —
Insider Thomas CatinazzoChief Financial Officer Buy (Option exercise) 169.45K sh $834.67K +14.2%+11.5% —
Insider Donald BergstromPresident, R&D Sell (Option exercise) 93.46K sh +14.2%+11.5% —
Insider Donald BergstromPresident, R&D Buy (Option exercise) 93.46K sh $385.04K +14.2%+11.5% Read

1W / 1M / 6M = how RLAY moved from the trade or filing date.

Insider trading in RLAY: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Patel Sanjiv President and CEO 1 -$872.40K Oct 7, 2026
Catinazzo Thomas Chief Financial Officer 1 -$329.32K Oct 6, 2026
Donald Bergstrom President, R&D 2 — Jun 22, 2026
Thomas Catinazzo Chief Financial Officer 1 — Jun 22, 2026

Frequently asked questions

Are RLAY insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $1.20M, a net -$1.20M.

What is the latest insider trade in RLAY?

Patel Sanjiv, President and CEO filed a sell (open-market sale) of 48.20K sh worth $872.40K on Oct 7, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text